ADRB2 is regulated by TRIM22 and facilitates lung adenocarcinoma progression via JAK2/STAT3 signaling pathway
Abstract Lung adenocarcinoma (LUAD) is the most common pathological subtype of lung cancer. Adrenergic signal has always been considered as an important link with the occurrence and development of cancer. Considerable evidence suggests that β-2 adrenergic receptor (ADRB2) shows an important role in...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06017-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!